ReWalk Robotics Ltd (NASDAQ:RWLK) shot up 12.3% on Tuesday . The stock traded as high as $1.60 and last traded at $1.55. 1,314,300 shares changed hands during mid-day trading, an increase of 274% from the average session volume of 350,974 shares. The stock had previously closed at $1.38.
Several research firms have recently weighed in on RWLK. Oppenheimer Holdings, Inc. set a $4.00 price objective on ReWalk Robotics and gave the company a “buy” rating in a research report on Friday, August 4th. Canaccord Genuity reduced their price objective on ReWalk Robotics from $4.00 to $3.00 and set a “buy” rating for the company in a research report on Friday, August 4th. Jefferies Group LLC reduced their price objective on ReWalk Robotics from $8.00 to $5.00 and set a “buy” rating for the company in a research report on Friday, November 3rd. Finally, Zacks Investment Research raised ReWalk Robotics from a “hold” rating to a “buy” rating and set a $1.50 price objective for the company in a research report on Thursday, November 9th. One investment analyst has rated the stock with a sell rating and four have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $3.00.
The company has a debt-to-equity ratio of 7.46, a quick ratio of 1.65 and a current ratio of 2.02.
A number of hedge funds have recently modified their holdings of RWLK. Advisor Group Inc. lifted its position in ReWalk Robotics by 1,495.6% in the third quarter. Advisor Group Inc. now owns 181,900 shares of the medical device company’s stock worth $264,000 after purchasing an additional 170,500 shares during the period. Essex Investment Management Co. LLC lifted its position in ReWalk Robotics by 328.7% in the third quarter. Essex Investment Management Co. LLC now owns 156,981 shares of the medical device company’s stock worth $228,000 after purchasing an additional 120,362 shares during the period. Finally, Renaissance Technologies LLC lifted its position in ReWalk Robotics by 61.7% in the first quarter. Renaissance Technologies LLC now owns 78,600 shares of the medical device company’s stock worth $165,000 after purchasing an additional 30,000 shares during the period. 4.62% of the stock is owned by hedge funds and other institutional investors.
About ReWalk Robotics
ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.
Receive News & Ratings for ReWalk Robotics Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics Ltd and related companies with MarketBeat.com's FREE daily email newsletter.